Cortisol Essentials
Cortisol Essentials, licence 80137729: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Researched Nutritionals
- NPN or DIN-HM
- 80137729
- Status
- Active licence
- Licence date
- 10 January 2025
- Revision date
- 10 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bacopa monnieri Source : Bacopa monnieri - plante entière | 75.0 mg | Not calculated |
| Cytidine 5'-diphosphocholine Source : Citicoline sodium | 62.5 mg | Not calculated |
| Phosphatidylsérine Source : Helianthus annuus - Graine | 25.0 mg | Not calculated |
| Hericium erinaceus Extract : Matériel brut frais Extraction ratio : 10:1 Dry plant equivalent : 2500 mg | 250.0 mg | Not calculated |
| Scutellaria lateriflora Source : Scutellaria lateriflora - Sommité (herbe) | 100.0 mg | Not calculated |
| Oryza sativa Source : Oryza sativa - Graine Potency : 25.0 % Anthocyanins | 100.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, L-Leucine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fungal polysaccharides with immunomodulating properties. Helps reduce cortisol and C reactive protein levels, biomarkers of physical stress. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Source of antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137729
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.